-+ 0.00%
-+ 0.00%
-+ 0.00%

RxSight Sees Q2 Sales $32.000M-$34.000M vs $32.077M Est

Benzinga·07/06/2026 20:50:58
Listen to the news
RxSight (NASDAQ:RXST) sees Q2 sales of $32.000 million-$34.000 million vs $32.077 million analyst estimate.